Abstract
Doxorubicin (DR) is a potential antineoplastic drug that is used for therapy of different types of malignant tumors (leukemia, lymphoma, mammary tumor, lung, ovarian, pancreatic tumor etc.). However, the long-term use of DR leads to irreversible cardiomyopathy and nephropathy due to DR-induced formation of free oxygen radicals that disturb the functionality of the mitochondria, membranes, and nuclei of cells. The mechanisms of DR-induced cardiotoxicity and nephrotoxicity associated with changes in the activity of antioxidant metalloproteins (Cu, Zn-SOD, Mn-SOD, and catalase) and prooxidant metalloproteins (acidic isoforms of cytochrome (cyt) b558 and cyt C) in heart and kidney cells are not clear. Here we tried to evaluate these biochemical factors.
Similar content being viewed by others
References
Lunnikova, E.L., Nepomnyashchikh, L.N., Klinnikova, M.G., and Sviridov, E.A., Byul. SO PAMN, 2008, vol. 6, no. 134, pp. 78–85.
Gilleron, M., Marchol, X., Montaigne, D., Franczak, J., Neviere, R., and Lancel, S., Biochem. Biophys. Res. Commun., 2009, vol. 388, no. 4, pp. 727–731.
Mukhopadhyay, P., Rajesh, M., Batkai, S., Kashiwaya, Y., Hasko, G., Liaudet, L., Szabo, C., and Pacher, P., Am. J. Physiol. Heart Circ. Physiol., 2009, vol. 296, no. 5, pp. 1466–1483.
Deng, S., Kruger, A., Kleschyov, A.L., Kalinowsvi, L., Daiber, A., and Wojnowski, L., Free Radic. Biol. Med., 2007, vol. 42, no. 4, pp. 466–473.
Tatlidede E., Şehirli Ö., Velioğlu-Öğünç A., Çetinel Ş., Yarat A., Süleymanoğlu S., Şener G. Free Radic. Biol. Med., 2009, vol. 43, no. 3, pp. 195–205.
Kang, Y.J., Chen, Y., and Epstein, P.N., J. Biol. Chem., 1996, vol. 271, no. 21, pp. 12610–12616.
Elberry, A.A., Abdel-Naim, A.B., Abdel-Sattar, E.A., Nagy, A.A., Mosli, H.A., Mohamadin, A.M., and Ashour, O.M., Food Chem. Toxicol., 2010, vol. 48, no. 5, pp. 1178–1184.
Todotova, V.K., Kaufman, V.K., Hennings, L., and Kleimberg, V.S., Nutr., 2010, vol. 140, no. 1, pp. 44–48.
Koti, B.C., Vishwanathswamy, A.H., Wagawade, J., and Thippeswamy, A.H., Indian J. Exp. Biol., 2009, vol. 47, no. 1, pp. 41–46.
Che, F.F., Liu, Y., and Xu, C.G., Schuan Da Xue Xue Bao Yi Xue Ban, 2010, vol. 41, no. 1, pp. 24–28.
Liu, Z., Song, X., Xin, Y., Wang, X., Yu, H., Bai, Y., Liu, J., Zhang, Ch., and Hui, R., Clin. Med. J. (Engl.), 2009, vol. 122, no. 21, pp. 2652–2656.
Injac, R., Boskovic, M., Perse, M., Koprivec-Furlan, E., Cerar, A., Djordjevic, A., and Strukelj, B., Pharmacol. Rep., 2008, vol. 60, no. 5, pp. 742–749.
Tavadyan, L.A., Galoyan, K.A., Harutunyan, L.A., Tonikyan, H.G., and Galoyan, A.A., Neurochem. Res, 2010, vol. 35, no. 6, pp. 947–952.
Simonyan, G.M., Nersesyan, A.K., Simonyan, R.M., Babayan, M.A., Simonyan, M.A., and Galoyan, A.A., Neirokhimiya, 2005, vol. 22, no. 2, pp. 125–130.
Aleksanyan, M.K., Simonyan, G.M., Khachatryan, A.R., Simonyan, R.M., Babayan, M.A., Shirinyan, V.S., Galoyan, K.A., Aleksanyan, S.S., Simonyan, M.A., and Galoyan, A.A., Vopr. Teoret. Klin. Med., 2010, vol. 13, no. 3, pp. 8–11.
Simonyan, G.M., Simonyan, R.M., and Simonyan, M.A., Armenian Patent, 1997, no. 341.
Mizutani, H., Tada-Dikawa, S., Hiraku, Y., Kojima, M., and Kawanishi, S., Life Sci., 2005, vol. 76, no. 3, pp. 1439–1453.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © L.H. Tadevosyan, L.N. Arakelyan, M.A. Simonyan, G.A. Kevorkian, A.A. Galoyan, 2011, published in Neirokhimiya, 2011, Vol. 28, No. 3, pp. 244–248.
Rights and permissions
About this article
Cite this article
Tadevosyan, L.H., Arakelyan, L.N., Simonyan, M.A. et al. The regulatory influence of galarmin on the level and activity of rat tissue metalloproteins after doxorubicin-induced nephro- and cardiotoxicity. Neurochem. J. 5, 215–219 (2011). https://doi.org/10.1134/S1819712411030123
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712411030123